Intraindividual Comparison of 99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand 99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer

Conclusion: PSMA scanning provided a clear advantage over bone scanning by reducing the number of equivocal findings in most patients. SPECT/CT was pivotal for differentiating bone metastases from extraosseous tumor lesions.

Source: Journal of Nuclear Medicine - September 4, 2018 Category: Nuclear Medicine Authors: Rathke, H., Afshar-Oromieh, A., Giesel, F. L., Kremer, C., Flechsig, P., Haufe, S., Mier, W., Holland-Letz, T., De Bucourt, M., Armor, T., Babich, J. W., Haberkorn, U., Kratochwil, C. Tags: Clinical Source Type: research